Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017111178) SOLID PREPARATION
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2017/111178 International Application No.: PCT/JP2016/089222
Publication Date: 29.06.2017 International Filing Date: 21.12.2016
IPC:
A61K 9/20 (2006.01) ,A61K 9/24 (2006.01) ,A61K 31/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
22
Sustained or differential release type
24
Layered or laminated unitary dosage forms
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
Applicants:
TAKEDA PHARMACEUTICAL COMPANY LIMITED [JP/JP]; 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka 5410045, JP
Inventors:
ISHII, Shiro; JP
Agent:
TAKASHIMA, Hajime; Meiji Yasuda Seimei Osaka Midosuji Bldg. 1-1, Fushimimachi 4-chome Chuo-ku, Osaka-shi Osaka 5410044, JP
Priority Data:
2015-25265724.12.2015JP
Title (EN) SOLID PREPARATION
(FR) PRÉPARATION SOLIDE
Abstract:
(EN) The problem of the present invention is provision of a solid preparation containing N-methyl-N- (1-methylethyl) - 6, 7, 8, 9-tetrahydropyrazino [2, 3-f] [1, 4] oxazepin-3-amine or a salt thereof, which may release the compound in a sustained manner. A solid preparation containing N-methyl-N- (1- methylethyl) -6, 7,8, 9-tetrahydropyrazino [2, 3-f] [1,4] oxazepin-3- amine or a salt thereof, and a hydrophilic gel-forming polymer.
(FR) L'objet de la présente invention est de fournir une préparation solide contenant du N-méthyle-N-méthyléthyl)-6,7,8, 9-tétrahydropyrazino[2, 3-f] [1, 4] oxazépin-3-amine ou un sel de celui-ci, qui peut libérer le composé de manière contrôlée. Il est aussi de fournir une préparation solide contenant du N-méthyl-N-( 1- méthyléthyl)-6,7,8, 9-tétrahydropyrazino [2, 3-f] [1,4] oxazépin-3-amine ou un sel de celui-ci, et un polymère hydrophile formant un gel.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)